| HIV-1 Adenovirus Type 4-Vectored (A549 cells) Vaccines (Ad4-Env150KN and Ad4-Env145NFL) |
VRC/NIAID/NIH |
July 2021 |
|
| HxB2.WT.Core-C4b, Adjuvanted |
DAIDS/NIAID/NIH |
October 2024 |
|
| ID93 + GLA Adjuvant Vaccine - New - New |
AAHI |
March 2024 |
|
| INO-6160 and INO-6172 - New - New |
DAIDS/NIAID/NIH |
February 2025 |
|
| mRNA-1574 Trimer Vaccines |
DAIDS/NIAID/NIH |
November 2024 |
|
| mRNA-1645-eODGT8 and mRNA-1645-CoreG28v2 |
Moderna |
October 2024 |
|
| mRNA-1645-N332GT5 |
Moderna |
October 2024 |
|
| MTBVAC |
Biofabri |
July 2024 |
|
| MVA-CMDR |
Walter Reed Army Institute Research (WRAIR) |
November 2019 |
|
| MVA.tHIVconsv3 Vaccine |
University of Oxford |
May 2024 |
|
| MVA.tHIVconsv4 Vaccine |
University of Oxford |
May 2024 |
|
| N-803 |
Altor BioScience (ImmunityBio) |
December 2023 |
|
| N332-GT5 gp140, Adjuvanted with SMNP |
DAIDS/NIAID/NIH |
July 2024 |
|
| p24CE1/2 multivalent pDNA Vaccine expressing HIV M Group p24 Gag and p55 gag pDNA with IL-12 pDNA |
NCI/NIAID/NIH |
November 2017 |
|
| PGDM1400 |
Beth Israel Deaconess Medical Center |
March 2021 |
|
| PGDM1400LS (VRC-HIVMAB0112-00-AB) - New - New |
DAIDS/NIAID/NIH |
March 2025 |
|
| PGT121 |
Beth Israel Deaconess Medical Center |
September 2020 |
|
| PGT121.414.LS (VRC-HIVMAB0107-00-AB) |
VCMP/NIAID/NIH |
June 2023 |
|
| Poly-ICLC (Hiltonol) - New - New |
Oncovir, Inc. |
January 2024 |
|
| RSV 276 |
LID/NIAID/NIH |
February 2019 |
|
